United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine tablets are indicated: sulfasalazine tablets are contraindicated in: none reported.

United States - English - NLM (National Library of Medicine)

remedyrepack inc. - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b) for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates. none reported.

United States - English - NLM (National Library of Medicine)

major pharmaceuticals - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg

Canada - English - Health Canada

pharmascience inc - sulfasalazine - tablet - 500mg - sulfasalazine 500mg - sulfonamides

Canada - English - Health Canada

pharmascience inc - sulfasalazine - tablet (enteric-coated) - 500mg - sulfasalazine 500mg - sulfonamides

United States - English - NLM (National Library of Medicine)

pd-rx pharmaceuticals, inc. - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg

United States - English - NLM (National Library of Medicine)

heritage pharmaceuticals inc. d/b/a avet pharmaceuticals inc. - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine tablets are indicated: a)    in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b)    for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in:     patients with intestinal or urinary obstruction,     patients with porphyria as sulfonamides have been reported to precipitate an acute attack,     patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates. none reported.

United States - English - NLM (National Library of Medicine)

aphena pharma solutions - tennessee, llc - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine tablets are indicated: - in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and - for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides or salicylates. none reported.

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine tablets are indicated: a) in the treatment of mild to moderate ulcerative colitis, and as adjunctive therapy in severe ulcerative colitis; and b) for the prolongation of the remission period between acute attacks of ulcerative colitis. sulfasalazine tablets are contraindicated in: patients with intestinal or urinary obstruction, patients with porphyria as sulfonamides have been reported to precipitate an acute attack, patients hypersensitive to sulfasalazine, its metabolites, sulfonamides, or salicylates. none reported.

United States - English - NLM (National Library of Medicine)

qualitest pharmaceuticals - sulfasalazine (unii: 3xc8guz6cb) (sulfasalazine - unii:3xc8guz6cb) - sulfasalazine 500 mg